Literature DB >> 6961269

Anatomical distribution of call antigen expressing cells in normal lymphatic tissue and in lymphomas.

G Hoffmann-Fezer, W Knapp, S Thierfelder.   

Abstract

Anatomical distribution of common acute lymphoblastic leukemia antigen (CALLA) was studied in lymphomas as well as in normal lymphatic organs using the monoclonal antibody VIL-A1. Twelve lymphomas were labelled by VIL-A1. Three of the 12 tumours also had T-cell marker, six lymphomas also showed immunoglobulin staining and only three tumours were pure CALLA lymphomas. Tonsils showed a distinct CALLA labelling of many germinal centre cells and of singular cells in interfollicular T-cell regions. Children's thymuses showed rare distinctly labelled cells in the cortex and medulla and slightly more cortical cells stained faintly by VIL-A1. Foetal thymuses of about the twelfth week of gestation contained many heavily labelled cells. The findings are discussed as evidence for the presence of CALLA on immature B as well as T lymphocytes. They favour the idea of CALLA as a common lymphocyte differentiation antigen although other possibilities of interpretation are also discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6961269     DOI: 10.1016/0145-2126(82)90057-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Expression of CD10 on lymphoid cells associated with thymoma.

Authors:  J Nakajima; S Takamoto; T Kohno; T Ohtsuka; J Matsumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-02

2.  Shortening the immunodeficient period after hematopoietic stem cell transplantation.

Authors:  Isabelle André-Schmutz; Emmanuelle Six; Delphine Bonhomme; Julien Rouiller; Liliane Dal Cortivo; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.

Authors:  M A Shipp; N E Richardson; P H Sayre; N R Brown; E L Masteller; L K Clayton; J Ritz; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Influence of pre-incubation with one antibody on the binding of a second by human lymphocytes.

Authors:  F Eichler-Reiss; P Reizenstein; G Mathé
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

5.  Monoclonal antibodies against differentiation antigens of lymphopoiesis.

Authors:  E Thiel
Journal:  Blut       Date:  1983-11

6.  Increase of CALLA-positive stimulated lymphoid cells in transient erythroblastopenia of childhood.

Authors:  S Leuschner; S Bödewaldt-Radzun; M Rister
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

7.  Cytotoxicity of monoclonal antibodies against individually immunophenotyped human leukemic cells.

Authors:  M Beksac; A Porwit-Ksiazek; R Hast; P Biberfeld; P Reizenstein
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Diagnostic specificity of the monoclonal anti-CALLA antibody VIL-A1 in leukemia and malignant lymphoma.

Authors:  W Knapp; D Lutz; P Bettelheim; T Radaszkiewicz; O Majdic; H Gadner
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

9.  Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis.

Authors:  M A Shipp; J Vijayaraghavan; E V Schmidt; E L Masteller; L D'Adamio; L B Hersh; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.